Aluminium clofibrate
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
- Increased Risk of Hyperlipidemia in Patients with Anxiety Disorders: a Population-Based Study
- (12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
- Regulatory Change in Pharmaceutical Price: Evidence from A
- PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
- NIH Public Access Author Manuscript Mutat Res
- Pharmaceutical Appendix to the Tariff Schedule 2
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- 'Essays in Regulation of Pharmaceutical Markets'
- (INN-Nimet) 8.12.2020
- Ivermectin Interest Group Submission
- The Effect of Short-Term Pretreatment with Peroxisome Proliferators on The
- Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
- Pharmaceuticals Appendix
- 1246 Cardiovascular Drugs
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving